Tuesday - August 26, 2025
FDA Approval of Pfizer-BioNTech COVID-19 Vaccine - Frequently Asked Questions'
September 22, 2021
WASHINGTON, Sept. 22 (TNSRep) -- The Congressional Research Service issued the following report (No. R46913) on Sept. 17, 2021, entitled "FDA Approval of the Pfizer-BioNTech COVID-19 Vaccine: Frequently Asked Questions" by legislative attorneys Kevin J. Hickey and Erin H. Ward and health policy analyst Agata Bodie:

* * *

SUMMARY

On August 23, 2021, the U.S. Food and Drug Administration (FDA) announced its regulatory approval of the Pfizer-BioNTech . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products